Ultralife ULBI

Ultralife FY 2022: revenue $131.8M, up 34%; diluted EPS $0.03

Form
10-K/A
Filed
Period
Importance
Routine
Document
10-K/A

Key figures from this report

These are the numbers Ultralife reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$131.8M+34% from $98.3M in FY 202110-K income statement, on EDGAR
  2. Net income−$119KAgainst −$234K in FY 202110-K income statement, on EDGAR
  3. Diluted EPS$0.03Against −$0.01 in FY 202110-K income statement, on EDGAR
  4. Cash and cash equivalents$5.6M−32% from $8.3M in FY 202110-K balance sheet, on EDGAR
  5. Cash from operations−$1.3M−129% from $4.3M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when Ultralife files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3690 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.